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A B S T R A C T
Products of ultraviolet (UV) irradiation such as reactive oxygen species (ROS) and nitric oxide (NO) stimulate
melanin synthesis. Reactive sulfur species (RSS) have been shown to have strong ROS and NO scavenging effects.
However, the instability and low retention of RSS limit their use as inhibitors of melanin synthesis. The free thiol
at Cys34 on human serum albumin (HSA) is highly stable, has a long retention and possess a high reactivity for
RSS. We report herein on the development of an HSA based RSS delivery system. Sulfane sulfur derivatives
released from sodium polysulfides (Na2Sn) react readily with HSA. An assay for estimating the elimination of
sulfide from polysulfide showed that almost all of the sulfur released from Na2Sn bound to HSA. The Na2Sn-
treated HSA was found to efficiently scavenge ROS and NO produced from chemical reagents. The Na2Sn-treated
HSA was also found to inhibit melanin synthesis in B16 melanoma cells and this inhibition was independent of
the number of added sulfur atoms. In B16 melanoma cells, the Na2Sn-treated HSA also inhibited the levels of ROS
and NO induced by UV radiation. Finally, the Na2Sn-treated HSA inhibited melanin synthesis from L-DOPA and
mushroom tyrosinase and suppressed the extent of aggregation of melanin pigments. These data suggest that
Na2Sn-treated HSA inhibits tyrosinase activity for melanin synthesis via two pathways; by directly inhibiting ROS
signaling and by scavenging NO. These findings indicate that Na2Sn-treated HSA has potential to be an attractive
and effective candidate for use as a skin whitening agent.
1. Introduction
Ultraviolet (UV) irradiation produces reactive oxygen species (ROS)
that ultimately cause cell death [1]. To protect the skin from UV da-
mage, melanin, a dark colored pigment, is produced by melanocytes
[2]. While melanin is essential for skin health, a demand for melanin
scavenging preparations exists. Chloasma (melasma) is a condition in
which the skin develops discolored areas that are caused by over-
production of melanin and are sometimes regarded as a metaphor of
aging. In addition, inhibitors of melanin synthesis are popular cosmetics
for brightening the skin, especially in Asian countries [3].
Tyrosinase catalyzes the production of melanin from tyrosine via
DOPA and dopaquinone in melanocytes [4]. Its activity is regulated by
a variety of factors such as ERK1/2 and Akt signaling [5]. ROS such as
hydrogen peroxide produced by UV irradiation, activates tyrosinase
and promotes melanin synthesis in melanocytes [2]. UV also causes the
production of nitric oxide (NO) and stimulates tyrosinase activity via
cGMP [6], a second messenger of NO.
On the other hand, thiol compounds with anti-oxidant effect has
been widely used as supplements, radioprotection agents and perm
agents [7]. Thiol-containing compounds undergo self-oxidation to form
sulfonic acid, sulfenic acid and sulfonic acid [8]. Thiol also scavenges
NO via S-nitrosation [8]. Because of these effects, thiol-containing
compounds are often used in treating chloasma [7,9]. However, the
skin whitening effect of thiols is very weak, a demand for more effective
ROS and NO scavenging agents exists.
Reactive sulfur species (RSS) including cysteine persulfide have
recently been reported to have stronger anti-oxidant effects than thiols.
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RSS contain a reactive thiol group [10] and the pKa of most RSS are
much lower than that for thiols [11]. Therefore, RSS can react effec-
tively with both ROS and NO and predicted to reduce the extent of
melanin production. Sodium polysulfides (Na2Sn), diallyltrisulfide
(DATS) and dimethyltrisulfides (DMTS) are commonly used as RSS
donors [12]. However, Na2Sn has a low retention at neutral pH and has
an offensive smell. In addition, DATS and DMTS, which are produced
by garlic and onions are also odorous and their potential for such
treatments is limited [13]. Furthermore, the half-life of Na2Sn is very
short in serum and, based on in vivo models, multiple injections are
needed for them to be effective. Thus, the development of novel RSS-
delivery-systems would be highly desirable.
Human serum albumin (HSA) is the most abundant protein in serum
and is widely used as a drug carrier because of its biocompatibility and
long plasma retention properties [14,15]. HSA contains a total of 35 Cys
residues and one of them, Cys34, is present in the form of a free thiol
group [16]. Cys34 is sometimes a target for a drug binding site, because
of its reactive thiol group [17,18]. For example, in the presence of nitric
oxide (NO) the Cys34 thiol group is S-nitrosated. We previously de-
monstrated that S-nitrosated HSA (SNO-HSA) allows NO to be retained
for long periods in serum [19]. SNO-HSA has various biological func-
tions, including a liver protective effect against ischemia/reperfusion
[20] and tumor suppressing effects [21].
Consequently, we hypothesized that HSA could be used as a RSS
carrier (such as SNO-HSA) via the S-sulfhydration of Cys34-SH. As a
source of polysulfur, DATS and DMTS are limited because of their li-
pophilicity and volatility. Hence, commercially available Na2Sn (Na2S,
Na2S2, Na2S3 and Na2S4) was used in this study. Ogasawara et al. pre-
viously prepared sulfur-bound serum albumin reacted with sodium
sulfide (NaHS) by a simple mixing of the reagents [22]. The sulfur from
NaHS was added to Cys34 and the resulting preparation protected liver
damage caused by lipid peroxide. We adopted this method for pre-
paring RSS-added-HSA using Na2Sn for RSS delivery.
In this work, we reported the preparation of Na2Sn-treated HSA and
its use as a novel delivery system of RSS. The added sulfur was analyzed
by means of a sulfane sulfur probe [23] and the elimination of sulfide
from polysulfide [24]. To evaluate the effect of Na2Sn-treated HSA on
skin whitening, the effect of the Na2Sn-treated HSA on melanin synth-
esis was studied using a B16 melanoma cell line.
2. Material and methods
2.1. Materials
Human serum albumin (HSA) was purchased from KAKETSUKEN
(Kumamoto, Japan) and all HSA samples were defatted by a charcoal
treatment. Sodium sulfide and sodium tetrasulfide were purchased from
DOJINDO Laboratory (Kumamoto, Japan). Sulfane sulfur probe 4
(SSP4) was prepared as previously described [23]. L-DOPA, glu-
tathione, (DTNB), ascorbic acid and sodium satiric Griess reagent
(sulfanilamide, naphthylethylenediamine-HCl) were purchased from
Nakarai Chemicals (Kyoto, Japan). Sephadex G-25 desalting column (φ
1.6 × 2.5 cm) was purchased from GE Healthcare (Kyoto, Japan).
Dulbecco's modified Eagle medium (DMEM) and 2,2-diphenyl-1-pi-
crylhydrazyl (DPPH) were obtained from Wako Pure Chemical (Osaka,
Japan). Mushroom tyrosinase was purchased from Sigma-Aldrich. All
other chemicals were of the best grade that was commercially available,
and all solutions were prepared in deionized and distilled water.
2.2. BCA protein assay
Protein concentrations were measured using a BCA protein assay.
10 μL aliquots of samples and bovine serum albumin (BSA) standards
were incubated in 100 μL of reaction buffer at 25 °C for 30 min. After
the reaction, micro-plate reader was used to measure the absorbance of
540 nm. BSA was used to construct a standard curve.
2.3. Synthesis of Na2Sn treated-HSA
HSA (300 μM) was incubated with 1 mM of sodium polysulfides
(Na2Sn) in PBS (pH 7.4) for 1 h at 37 °C. After the reaction, excess so-
dium polysulfides were removed by gel filtration with a Sephadex G-25
column.
2.4. Determination of sulfur binding rate by elimination method for sulfide
from polysulfide (EMSP)
EMSP was prepared as previously described (3×EMSP by addition
of 792 mg of L-ascorbic acid to 5 mL of 3 N of NaOH) [24]. Samples
(7.5 μM, 133 μL) were incubated with 66.7 μL of 3×EMSP for 3 h at
37 °C. A 1% zinc acetate solution (600 μL) was then added to the re-
action solution, followed by vortexing immediately. The samples were
centrifuged at 8,000×g for 5 min and washed with phosphate buffered
saline (PBS) twice. After removing the supernatants, deionized and
distilled water (200 μL) was added to the precipitates. After adding 1%
zinc acetate (300 μL), 50 μL of 20 mM N,N-dimethyl-p-phenylenedia-
mine and 20 mM FeCl3 in 7.2 N HCl, the solution was incubated for
30 min at 25 °C. Samples were centrifuged at 8000×g for 1 min and
transferred into 96-well plates and the OD at 665 nm measured. Na2S
was used to construct a standard curve.
2.5. Detection of sulfane sulfur with SSP4
Each sample (20 μM) was incubated with 5 μM of SSP4 in 1 mM
Cetyltrimethylammonium Bromide / PBS (pH 7.4) for 10 min at 25 °C.
After incubation, the fluorescence measured by a spectrophotometer
(JASCO Corporation) with excitation at 457 nm, emission at
490–535 nm.
2.6. DPPH radical tests
DPPH (250 μM) in ethanol was mixed with the same amount of MES
buffer (50 mM, pH 7.4). Na2Sn-treated HSA (40 μM) was the added to
this DPPH solution, which was then incubated for 30 min at 25 °C and
the absorbance of the DPPH radicals was measured at 540 nm.
Scavenged radical rates were converted using the following formula;
Scavenged radical (%) = (Abssample-Abspbs)/ Abspbs × 100
2.7. NO and SNO analysis
Na2Sn-treated HSA (50 μM) was incubated with an NO donor, NOC7
(200 μM), for 30 min at 25 °C. After the reaction, the concentration of
NO and SNO were measured by a Griess assay with minor modifications
[25]. The Griess reagent solution was prepared by mixing 0.1% N-1-
Naphtylethylene-diamide dihydrochloride and 1% sulfanilamide in 2%
phosphoric acid. The reaction buffer was composed of 0.1 M NaCl,
0.5 mM DTPA and 10 mM AcONa･AcOH (pH 5.5). Samples (20 μM)
were reacted with the Griess reagent solution (60 μL) in reaction buffer
(110 μL) with 3 mM HgCl2 in 10 mM Na Acetate (pH 5.5). After a
15 min incubation, the absorbance of 540 nm was measured by means
of a microplate reader. The remaining NO/SNO ratio (%) was calcu-
lated and compared to PBS values for the samples.
2.8. Cell culture
B16 melanoma cells were provided by the Japanese Cancer
Research Resources Bank (JCRB, Tokyo, Japan), and were cultured in
DMEM containing 10% fetal bovine serum and an antibiotics solution.
Cells were grown with maintained at 37 °C in humidified air containing
5% CO2 in incubator (passage number 10–20).
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2.9. Melanin production
B16 melanoma cells were seeded in 24 well plates at a concentration
of 2.5×104 cells/well and cultured under 5% CO2 at 37 °C for 24 h.
Samples were treated with 0.4 mM tyrosine and 10 mM NH4Cl in
DMEM containing 10% FBS and then incubated under 5% CO2 at 37 °C
for 72 h. After the incubation, the cells were washed twice with PBS and
dissolved in 1 N NaOH (200 μL). After a 2 h incubation on 60 °C, the
absorption (405 nm) was measured by means of a micro-plate reader.
2.10. UV radiations
A hand held UV lamp was used to irradiate the samples at a distance
of 5 cm distance from the well plate. This UV lamp provides a UV in-
tensity of 614 or 743 μW/cm2 respectively with 254 nm or 365 nm
radiation from a distance of 5 cm.
2.11. Scavenging activity of Na2S4-treated HSA against intracellular ROS,
NO, RSS
ROS and NO in B16 melanoma cells were measured by each of the
fluorescence probes, CM-H2DCF-DA and DAF-FM-DA, respectively. B16
melanoma cells were seeded in 96-well plates at a concentration of 1 ×
104 cells/well and cultured in 37 °C, 5% CO2 for 24 h. After culturing,
the media was removed and replaced with CM-H2DCF-DA (5 μM) or
DAF-FM-DA (10 μM) in PBS. The probes were taken up by the cells by
incubating them at 37 °C for 30 min. After the reaction, the super-
natants were removed, the samples diluted in PBS and the fluorescence
measured immediately. Cells were radiated by a UV lamp for 15 min.
After the irradiation, the fluorescence intensity (Ex. 485 nm, Em.
535 nm) was measured by means of a fluorescence micro-plate reader.
2.12. Mushroom tyrosinase activity and melanin aggregation
Tyrosinase and L-DOPA solutions were prepared in PBS (pH 7.4)
immediately before the assay. Tyrosinase, isolated from mushrooms,
was used for examining the inhibitory activity of Na2Sn-treated HSA. A
20 μL portion of mushroom tyrosinase (537 U/mL) and 100 μL of
Na2Sn-treated HSA (40 μM) were mixed well with PBS (60 μL) in 96
well plates and 20 μL of L-DOPA (5 mM) was then added. After a 30 min
incubation, the level of synthesized melanin was analyzed by measuring
the OD 490 nm. For assaying melanin aggregation, the mixture was
centrifuged at 20,000 g, 15 min for 3 h. The white arrow shows the
aggregated material. Non-aggregated melanin in the supernatant was
measured at an OD of 490 nm.
2.13. Safety tests
The topical cream used in this study was prepared by mixing water
(30 mL) Jojoba Oil (15 mL) and 5 g of emulsifying wax at 60 °C. After
cooling, the Na2S4-treated HSA (20 μM) and the resulting suspension
were mixed well. The Skin Irritation Test was done following the OECD
Test Guideline 439 using the LabCyte Epi-Model (a 3D cultured human
skin model).
2.14. Statistical analysis
The statistical significance of the collected data was evaluated by
ANOVA analysis followed by Newman-Keuls method for more than 2
means. Differences between the groups were evaluated by Student's t-
test. P< 0.05 was regarded as being statistically significant.
3. Results
3.1. Preparation of S-sulfydrated HSA
Na2Sn-treated HSA was prepared from HSA that had been incubated
with Na2Sn and subjected to gel filtration after the reaction. To assess
the amount of sulfane sulfur in the sample, EMSP, a novel quantitative
method we previously developed, was employed [24]. Hence, Na2S4-
treated HSA was prepared from HSA and Na2Sn by allowing the re-
agents to react for 1 h at 37 °C. Different amounts of sodium poly-
sulfides were allowed to react with HSA. Then, the HSA samples were
incubated with EMSP solution, which was prepared at time of use, for
3 h at 37 °C. Based on the EMSP analyses, the level of S-sulfydration
increased independently of the amount of sulfur (Fig. 1A). On the other
hand, as shown in Fig. 1B, the Na2S3- or Na2S4-treatment enhanced the
SSP4 (a fluorescence probe for sulfane sulfur) fluorescence intensity
compared with the Na2S- or Na2S2-treatments, suggesting that SSP4
possibly reacted with the polysulfide of the protein in a non-linear
manner (Fig. 1B).
3.2. Antioxidant and NO suppressive effect of Na2S-treated HSA
We postulated that Na2Sn-treated HSA would suppress melanin
production because of its antioxidant activity. Hence, a DPPH radical
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Fig. 1. Polysulfur binding to HSA by incubation with sodium polysulfide. (A) Valance
dependency for adding sulfur to HSA with Na2Sn. Sulfane sulfur in Na2Sn-treated HSA
samples were measured by EMSP. The values were subtracted from the untreated HSA.
(B) SSP2 fluorescence intensity of Na2Sn-treated HSA samples was analyzed by SSP2. Each
value represents the mean± S.E. (n = 3). *p< 0.05 as compared with HSA.
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test [26,27] was carried out to analyze the antioxidant activity in vitro.
As a result, the Na2Sn-treated HSA had a significantly higher con-
centration of added sulfur (Fig. 2A). To elucidate the effect of NO,
NOC7 (a NO donor) was co-incubated with Na2S4-treated HSA at 25 °C.
After a 30 min period of incubation, the remaining NO concentration
was quantitated by a Griess assay. As seen in the closed bars of Fig. 2B,
the Na2S4-treated HSA scavenged significantly more NO compared with
the control and HSA (Fig. 2B). Elemental mercury (Hg) is known to
reduce SNO and release NO2-. When Hg was added to a solution of
Na2S4-treated HSA, NO2- was released, suggesting that the Na2S4-
treated HSA was scavenged via S-nitrosation.
3.3. Melanin suppress effect of Na2Sn-treated HSA
B16 mice melanoma cells were cultured and melanin synthesis was
promoted by adding tyrosine to the media. As shown in Fig. 3, the
Na2Sn-treated HSA inhibited melanin synthesis and the inhibition was
dependent on the sulfur content. Cell images of B16 melanoma cells
after the application of the Na2Sn-treated HSA also demonstrated that
Na2Sn-treated HSA decreased the ratio of production of melanin
positive cells (Fig. 3).
3.4. Antioxidant effect of Na2S4-treated HSA with irradiation of UV
To examine whether the Na2Sn-treated HSA suppressed the forma-
tion of UV-induced ROS or NO, an oxidative stress test was performed
using B16 melanoma cells as models. ROS production by Na2S4-treated
HSA in B16 melanoma cells by irradiation with 2 different UV devices
for 15 min was measured by CMH2-DCF-DA. The findings indicate that
the Na2S4-treated HSA caused a significant decrease in the fluorescence
of CMH2-DCF-DA to PBS and HSA by irradiation at 254 nm and 365 nm
(Fig. 4AB). Conversely, the Na2S4-treated HSA also suppressed the
production of NO in B16 melanoma cells by irradiation with 254 nm UV
(Fig. 4CD). These results indicate that Na2Sn-treated HSA suppresses
melanin synthesis by inhibiting ROS and NO produced by UV irradia-
tion.
3.5. Direct suppression of tyrosinase and melanin aggregation by Na2Sn-
treated HSA
Some commercial anti-melanin agents are known to directly inhibit
tyrosinase activity. Thus, we tested whether the Na2Sn-treated HSA
altered the activity of tyrosinase. The findings indicated that the Na2Sn-
treated HSA inhibited mushroom tyrosinase to a greater extent than
non-treated HSA (Fig. 5A). After being generated, melanin readily un-
dergoes aggregation and induces medulla formation [28]. Therefore,
we next addressed the issue of whether Na2Sn-treated HSA inhibits the
aggregation of melanin. Consequently, when tyrosinase and L-DOPA
were incubated together for 3 h, melanin pigments became aggregated,
but the Na2Sn-treated HSA prevented the aggregation (Fig. 5B). On the
one hand, HSA was also found to inhibit aggregation, indicating that
HSA itself could prevent the binding of L-DOPA to tyrosinase.
3.6. Safety test of Na2Sn-treated HSA using 3D cultured human skin
Skin irritation tests for the Na2S4-treated HSA was performed using
3D cultured human skin cells according to OECD guidelines. As a result,
the numbers of surviving cells were not decreased by Na2S4-treated
HSA with/without the use of a topical cream (Fig. 6A). The use of an
LDH cytotoxicity detection kit also revealed that skin cells were not
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damaged by the Na2S4-treated HSA (Fig. 6B). These data indicated that
Na2Sn-treated HSA is very safe for use against human skin under the
concentrations examined in this study.
4. Discussion
Melanin is synthesized by the oxidation of tyrosine. Tyrosine is
oxidized to L-DOPA, and then dopaquinone by the action of tyrosinase.
Dopaquinone is spontaneously oxidized to melanin. Melanin induces
the formation of black pigments and freckles, but also plays a role in
protecting the skin from being damaged by UV radiation. In human
skin, melanocytes produce ROS and NO when stimulated by UV ra-
diation [2,29,30]. ROS promotes melanin synthesis by activating tyr-
osinase via the action of ATP synthase, phenylalanine hydroxylase, and
the phosphorylation of MAPKs [31,32]. NO activates tyrosinase via
increasing the cellular level of cGMP [6]. Therefore, ROS and NO sca-
vengers are considered to be anti-melanogenesis agents. Here, we in-
vestigated the anti-melanin synthesis effect of Na2Sn-treated HSA.
Na2Sn-treated HSA strongly suppressed the cellular levels of ROS and
NO produced by UV radiation (Fig. 4). Furthermore, Na2Sn-treated HSA
had a direct effect on inhibiting the action of tyrosinase (Fig. 5A) and
the aggregation of melanin (Fig. 5B). We were not able to clarify the
mechanism for how sulfane sulfur was transferred from the Na2Sn-
treated HSA to a cell. Therefore, the nature of how the direct effects of
Na2Sn-treated HSA function remain unclear. Yamashita et al. demon-
strated that dopaquinone binds to thiol proteins via cysteine residues
[33]. Taken together, the inhibition of melanin aggregation by HSA and
Na2Sn-treated HSA may also involve the formation of disulfide bonds
with dopaquinone or melanin. On the other hand, tyrosinase inhibition
was dependent on the content of added sulfur (Fig. 5A). GSH is known
to bind tyrosinase and decrease its activity [34]. Because S-sulfhydrated
cysteine has a stronger reactivity than normal cysteine [11], glu-
tathione persulfide (GSSH) may inhibit the action of tyrosinase more
than GSH. Further studies regarding the issue of whether Na2Sn-treated
HSA increases intracellular GSSH is needed in the future.
ROS are produced by UV irradiation or external stress induce signs
of aging, not only in the form of melanin synthesis but also by the
appearance of wrinkles and sagging skin, caused by DNA damage and
the formation of cross linked collagen. It is also known that ROS are an
aggravating factor in various types of inflammation such as pimples and
psoriasis. Various skin whitening agents, such as tranexamic acid [35]
and arbutin [36], have been designed to address these issues. However,
these compounds only inhibit melanin synthesis and have no effect on
oxidative stress. Thus, the risks of ROS-induced toxicity remained. An
advantage of using Na2Sn-treated HSA is that it efficiently scavenges
ROS (Figs. 2 and 4).
Hydrogen sulfide has been studied as a third essential molecule after
nitric oxide and carbon monoxide. Therapeutic effects of hydrogen
sulfide have been shown to be applicable to the treatment of ischemia/
reperfusion [37], atherosclerosis [38], sepsis [39] and high fat diet-
induced toxicity [40]. In addition, hydropersulfide has a higher activity
than hydrogen sulfide. For example, Na2S4 effectively detoxifies methyl
mercury and inhibits the differentiation of neuroblastoma cells, while
Na2S does not [12,41]. Therefore, not only a skin whitening effect but
also other positive effects of Na2Sn-treated HSA are possible.
In conclusion, we reported on the development of a novel RSS de-
livery system using serum albumin as a stable carrier. Reactive sulfur,
when combined with HSA, had a stronger anti-oxidant effect than HSA
and inhibited melanin synthesis in melanoma cells. The mechanism of
anti-melanogenesis involves not only ROS and NO scavenging, but also
Fig. 4. ROS and NO scavenging effects of
Na2S4-treated HSA under UV irradiation.
ROS in B16 melanoma cells was detected by
CM-H2DCF-DA in the presence of HSA and
Na2S4-treated HSA with 15 min irradiation
of 2 different UV, (A) 254 nm, (B) 365 nm.
Each value represents the mean± S.E. n =
3. **p< 0.01 as compared with control.
##p<0.01 as compared with HSA. NO in
B16 melanoma cells was detected by DAF-
FM-DA in the presence of HSA and Na2S4-
treated HSA after irradiation for 15 min
with 2 different wavelengths, (C) 254 nm,
(D) 365 nm. NO synthesis was measured by
DAF-FM-DA. Each value represents the
mean± S.E. n = 3. *p< 0.05, **p< 0.01
as compared with control. ##p<0.01 as
compared with PBS.
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suppression of tyrosinase activity and melanin aggregation. Hence,
Na2Sn-treated HSA has considerable potential for use as a safe skin
whitening agent.
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